Promoting Collaboration of Regulators and Patients in Improving Drug Safety and Regulatory Decision Making

Yoong Khean Khoo (), John C. W. Lim, Wei Chuen Tan-Koi, Nokuthula Sikhethiwe Kitikiti and Ai Ling Sim-Devadas
Additional contact information
Yoong Khean Khoo: Duke-NUS Medical School
John C. W. Lim: Duke-NUS Medical School
Wei Chuen Tan-Koi: Duke-NUS Medical School
Nokuthula Sikhethiwe Kitikiti: Duke-NUS Medical School
Ai Ling Sim-Devadas: Nanyang Technological University

Drug Safety, 2024, vol. 47, issue 3, No 3, 217-225

Abstract: Abstract Pharmacovigilance involves a continuous process of evaluating, monitoring and communicating the safety profile of a medicine throughout its life cycle. This process involves a range of stakeholders, including national regulatory authorities, industry, health organisations, healthcare providers and patients. Although patients are the end users of medicines and experts in their medical conditions, patient involvement is still nascent in the Asia-Pacific region. While there are positive examples and encouraging trends, several key challenges currently hinder systemic patient involvement in drug safety and regulatory decision making. Systemic issues such as a lack of formalised frameworks or platforms, underdeveloped communication and information exchange channels, and paternalistic health systems constrain greater patient involvement and collaborative regulator-patient activities. Addressing these challenges will greatly advance collaboration among regulators, patients, and patient advocates to enhance drug safety and regulatory decision making.

Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-023-01385-2 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:47:y:2024:i:3:d:10.1007_s40264-023-01385-2

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-023-01385-2

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().